Taikang Asset Management (Hong Kong) CO LTD Legend Biotech Corp Transaction History
Taikang Asset Management (Hong Kong) CO LTD
- $667 Million
- Q4 2024
A detailed history of Taikang Asset Management (Hong Kong) CO LTD transactions in Legend Biotech Corp stock. As of the latest transaction made, Taikang Asset Management (Hong Kong) CO LTD holds 100,475 shares of LEGN stock, worth $3.52 Million. This represents 0.49% of its overall portfolio holdings.
Number of Shares
100,475
Previous 48,330
107.89%
Holding current value
$3.52 Million
Previous $2.36 Million
38.81%
% of portfolio
0.49%
Previous 0.25%
Shares
5 transactions
Others Institutions Holding LEGN
# of Institutions
232Shares Held
84MCall Options Held
260KPut Options Held
387K-
Ra Capital Management, L.P. Boston, MA7.51MShares$263 Million3.96% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.81MShares$239 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$210 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$201 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$200 Million0.86% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.87B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...